Medicine & Life Sciences
Nitric Oxide
100%
Asthma
95%
Macular Degeneration
86%
darolutamide
83%
axicabtagene ciloleucel
79%
Child
71%
secukinumab
66%
venetoclax
65%
Cost-Benefit Analysis
62%
Randomized Controlled Trials
59%
Exsanguination
58%
Balloon Occlusion
54%
Cytarabine
46%
National Institutes of Health (U.S.)
42%
Psoriasis
40%
Acute Myeloid Leukemia
39%
Adrenal Cortex Hormones
38%
Non-Hodgkin's Lymphoma
38%
Eye
38%
Androgens
37%
Aorta
35%
Visual Acuity
35%
Therapeutics
33%
Hospital Emergency Service
32%
Prostatic Neoplasms
32%
Delivery of Health Care
30%
Hormones
28%
Optical Coherence Tomography
28%
Fluorescein Angiography
28%
Biomarkers
26%
Drug Therapy
24%
Standard of Care
23%
Random Allocation
23%
Quality-Adjusted Life Years
21%
Wounds and Injuries
19%
Health Care Costs
18%
Costs and Cost Analysis
17%
Mortality
16%
Odds Ratio
14%
Evaluation Studies
12%
Primary Health Care
10%
Hemorrhage
10%
Ocular Vision
9%
Health Care Outcome Assessment
9%
Quality of Life
8%
Secondary Care
8%
Photography
8%
Child Care
7%
Confidence Intervals
6%
Cause of Death
6%
Social Sciences
diagnostic study
63%
coherence
21%
costs
10%
diagnostic
8%
monitoring
7%
life years
6%
examination
5%
confidence
5%